GE Healthcare MR superconducting magnets, a component of GE 0.7T SIGNA OpenSpeed with Excite MR System, nuclear magnetic resonance imaging system.
Published February 16, 2022 · Recall initiated: December 23, 2021
Summary
FDA records medical device Class II recall Z-0608-2022, published February 16, 2022 and initiated December 23, 2021. Recalling firm: GE Healthcare, LLC; Status: Ongoing; Reported quantity: 17,228 devices total in this field correction; Lot: All systems. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
The magnetic resonance systems could potentially have a cryogen ventilation system that does not meet the venting requirements.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- GE Healthcare, LLC
- Distributor
- Distribution was nationwide, including Puerto Rico and the Virgin Islands. There was also government and military distribution. Foreign distribution was made to Albania, Algeria, Argentina, Armenia, Australia, Austria, Azerbaidjan, Bahrain, Bangladesh, Belarus, Belgium, Bhutan, Bolivia, Bosnia and Herzegovina, Botswana, Brazil, Bulgaria, Cambodia, Canada, Chile, China, Colombia, Republic of Congo, Croatia, Cyprus, Czech Republic, Denmark, Djibouti, Dominican Republic, Ecuador, Egypt, Equatorial Guinea, Estonia, Ethiopia, Finland, France, Georgia, Germany, Ghana, Greece, Guatemala, Honduras, Hong Kong, Hungary, India, Indonesia, Iran, Iraq, Ireland, Israel, Italy, Jamaica, Japan, Jordan, Kazakhstan, Kenya, Korea, Kuwait, Kyrhyzstan, Latvia, Lebanon, Libyan Arabic Jamahiriya, Lithuania, Luxembourg, Macedonia, Madagascar, Malaysia, Mali, Malta, Mauritania, Mexico, Republic of Moldova, Morocco, Mozambique, Myanmar, Nepal, Netherlands, New Zealand, Nicaragua, Nigeria, Nordic-HQ, Norway, Oman, Pakistan, State of Palestine, Panama, Paraguay, Peru, Philippines, Poland, Portugal, Qatar, Romania, Russia, Rwanda, Saudi Arabia, Serbia, Singapore, Slovakia, Slovenia, South Africa, Spain, Sri Lanka, Sudan, Swaziland, Sweden, Switzerland, Syria, Taiwan, Tanzania, Thailand, Trinidad and Tobago, Tunisia, Turkey, Ukraine, United Arab Emirates, United Kingdom, Uruguay, Uzbekistan, Venezuela, Vietnam, Zambia, and Zimbabwe.
- Lot
- All systems.
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDACentricity PACS Software Version 7.0 SP0.0.4.7August 3, 2022
- FDASIGNA Premier magnetic resonance scanner, model 5748519.July 27, 2022
- FDAGE Centricity Universal Viewer Zero Footprint. To view, communicate, process, and display Medical images andJuly 13, 2022
- FDABack up batteries in Avance CS2 and Avance CS2 Pro anesthesia devices manufactured on or after April 1, 2019July 6, 2022
- FDAGE Healthcare MR superconducting magnets, a component of GE Healthcare SIGNA 1.5T TwinSpeed MR System, nuclearFebruary 16, 2022
- FDAGE Healthcare MR superconducting magnets, a component of GE Healthcare SIGNA 3.0T MR System, nuclear magneticFebruary 16, 2022
Questions about this recall
Was GE Healthcare MR superconducting magnets, a component of GE 0.7T SIGNA OpenSpeed with Excite MR System, nuclear magnetic resonance imaging system. recalled?
Yes. FDA published recall Z-0608-2022 on February 16, 2022. Reported hazard: The magnetic resonance systems could potentially have a cryogen ventilation system that does not meet the venting requirements.
What should I do if I have this product?
Voluntary: Firm initiated · Letter